膀胱肿瘤标志物尿检的研究进展  

Progress in Tumor Markers of Bladder Tumor

作　　者：丁睿[1] 顾沈阳[1] 

机构地区：[1]江苏省苏北人民医院泌尿外科,江苏扬州225001

出　　处：《医学综述》2008年第18期2755-2758,共4页Medical Recapitulate

基　　金：江苏省卫生厅计划项目(H200769)

摘　　要：膀胱肿瘤发病率在恶性肿瘤中居第7位,其复发进展及生存期可能和许多因素有关。目前尚无单独的标志物对其诊断和治疗有明显的意义。因此,联合检测几种肿瘤标志物或改进现有的检测方法将有助于提高膀胱肿瘤诊断的准确度。The prevalence of bladder cancer is listed in the number seven in that of malignant tumors worldwide, and numerous factors are likely to be involved in their recurrence, progression, and survival times. Several molecular markers have been investigated, but no individual marker has been able to make a significant impact in diagnosis and management of this disease. Therefore, it is helpful for diagnosis of bladder cancer to detect several markers at the same time or improve current diagnostic methods.

关 键 词：膀胱肿瘤 肿瘤标志物 SURVIVIN 膀胱肿瘤抗原 血管内皮细胞生长因子 

分 类 号：R737.1[医药卫生—肿瘤]